Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study [Journal Neuromuscular Diseases May 2023]
Posted byTerri Fettinger
This is a widget ready area. Add some and they will appear here.
